Patents by Inventor Imad Matouk

Imad Matouk has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Nucleic acid agents for downregulating H19, and methods of using same
    Patent number: 8067574
    Abstract: Isolated oligonucleotides capable of down-regulating H19 mRNA in cancer cells are disclosed, as well as pharmaceutical compositions that include the oligonucleotides and methods of treatment of cancer using them. Methods of treating cancer comprising administering agents capable of downregulating H19 mRNA in combination with an additional anti-cancer treatment are further disclosed.
    Type: Grant
    Filed: January 16, 2008
    Date of Patent: November 29, 2011
    Assignee: Yissum Research Development Company of the Hebrew University of Jerusalem
    Inventors: Avraham Hochberg, Imad Matouk
  • Nucleic acid agents for downregulating H19 and methods of using same
    Patent number: 8067573
    Abstract: The present invention provides isolated oligonucleotides capable of down-regulating a level of H19 mRNA in cancer cells. Articles of manufacture comprising agents capable of downregulating H19 mRNA in combination with an additional anti-cancer treatment are disclosed as well as methods of treating cancer by administering same.
    Type: Grant
    Filed: July 6, 2006
    Date of Patent: November 29, 2011
    Assignee: Yissum Research Development Company of the Hebrew University of Jerusalem
    Inventors: Avraham Hochberg, Imad Matouk
  • NUCLEIC ACID AGENTS FOR DOWNREGULATING H19, AND METHODS OF USING SAME
    Publication number: 20090203121
    Abstract: Isolated oligonucleotides capable of down-regulating H19 mRNA in cancer cells are disclosed, as well as pharmaceutical compositions that include the oligonucleotides and methods of treatment of cancer using them. Methods of treating cancer comprising administering agents capable of downregulating H19 mRNA in combination with an additional anti-cancer treatment are further disclosed.
    Type: Application
    Filed: January 16, 2008
    Publication date: August 13, 2009
    Inventors: Avraham HOCHBERG, Imad Matouk
  • NUCLEIC ACID AGENTS FOR DOWNREGULATING H19 AND METHODS OF USING SAME
    Publication number: 20090143321
    Abstract: The present invention provides isolated oligonucleotides capable of down-regulating a level of H19 mRNA in cancer cells. Articles of manufacture comprising agents capable of downregulating H19 mRNA in combination with an additional anti-cancer treatment are disclosed as well as methods of treating cancer by administering same.
    Type: Application
    Filed: July 6, 2006
    Publication date: June 4, 2009
    Inventors: Avraham Hochberg, Imad Matouk